Abstract
A feature of many B-cell tumors is a surface-expressed immunoglobulin (sIg). The complementarity determiningregions (CDRs)of the sIg, termed the 'idiotype', are unique to each tumor. We report on a phage selection strategy to generate anti-idiotype therapeutics that react with sIg CDR3 sequences: the MEC1 B-cell tumor line was used as proof of concept. To create a mimetic of the MEC1 idiotype, CDR3 sequences from heavy and light chains of the sIg were grafted into a scFv framework scaffold. Using the Tomlinson I phage library of human scFvs, we enriched for binders to MEC1 CDR3 sequences over unrelated CDR3 sequences. By ELISA we identified 10 binder phage. Of these, five were sequenced, found to be unique and characterized further. By flow cytometry each of the five phage bound to MEC1 cells, albeit with different patterns of reactivity. To establish specificity of binding and utility, the scFv sequences from two of these binders (phage 1, and 7) were converted into antibody-toxin fusion proteins (immunotoxins) and also cloned into a human IgG1 expression vector. Binder-1 and -7 immunotoxins exhibited specific killing of MEC1 cells with little toxicity for non-target B-cell lines. The full-length antibody recreated from the bi...Continue Reading
References
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P CarterH M Shepard
Oct 22, 1992·The New England Journal of Medicine·L W KwakR Levy
Jan 1, 1991·Infection and Immunity·M OgataD FitzGerald
Mar 4, 1982·The New England Journal of Medicine·R A MillerR Levy
Mar 10, 1999·Leukemia Research·A StacchiniF Caligaris-Cappio
Aug 10, 2000·Immunity·J L Xu, M M Davis
Dec 13, 2003·Leukemia·J J M van DongenE A Macintyre
Oct 28, 2008·Blood Reviews·Roch Houot, Ronald Levy
Apr 7, 2009·Blood·Weiyun Z AiRonald Levy
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen J SchusterLarry W Kwak
Oct 15, 2011·Cancer Research·David J FitzGeraldIra Pastan
Mar 15, 2012·Blood·Andreas AgathangelidisKostas Stamatopoulos
Mar 23, 2012·Nature Reviews. Cancer·Andrew M ScottLloyd J Old
Jul 13, 2012·The Journal of Biological Chemistry·Jichun MaDi Xia
Aug 22, 2012·Methods in Molecular Biology·Masanori Onda
Dec 26, 2012·Frontiers in Oncology·Thomas Kieber-EmmonsHeinz Kohler
Sep 26, 2013·Seminars in Cancer Biology·Carsten U Niemann, Adrian Wiestner
Apr 11, 2014·Immunologic Research·Michael S Khodadoust, Ash A Alizadeh
May 7, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald LevyDan W Denney
Jul 26, 2014·Journal of Translational Medicine·Pier Adelchi RuffiniBjarne Bogen
Dec 3, 2014·Seminars in Oncology·Ulrich H WeidleUlrich Brinkmann
Dec 3, 2014·Seminars in Oncology·Sumita TrivediRobert L Ferris
Dec 3, 2014·Seminars in Oncology·Francesco SabbatinoCristina R Ferrone
Feb 6, 2016·British Journal of Haematology·Zadie DavisDavid Oscier